2-METHYLPROP ANAMIDES AND THEIR USE AS PHARMACEUTICALS
申请人:Yao Wenqing
公开号:US20100137401A1
公开(公告)日:2010-06-03
The present invention relates to inhibitors of 11-β hydroxyl steroid dehydrogenase type 1, antagonists of the mineralocorticoid receptor (MR), and pharmaceutical compositions thereof. The compounds of the invention can be useful in the treatment of various diseases associated with expression or activity of 11-β hydroxyl steroid dehydrogenase type 1 and/or diseases associated with aldosterone excess.